Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
alopecia
Biotech
Amgen's lupus bets continue to tumble, even those on the Horizon
Recently acquired Horizon Therapeutics reported that its mid-stage lupus candidate failed to significantly improve the condition compared to placebo.
Max Bayer
Jul 24, 2023 8:59am
Do hairy moles hold the key to treating hair loss?
Jun 22, 2023 5:01am
Sun's $576M Concert hits bum note as FDA imposes partial hold
May 2, 2023 7:09am
Concert persuades FDA to keep alopecia therapy breakthrough tag
Feb 15, 2023 10:00am
'Expect us to act' on M&A, AbbVie CEO says
Feb 9, 2023 2:29pm
Concert joins Sun Pharma's symphony in $576M acquisition
Jan 19, 2023 11:30am